Home

Pharma China Web Edition

Pharma China Archives

Online Databases

Order/Download/Info

Event Calendar

China Pharma Providers

About Us

Sign in | New Member Registration | Retrieve Password	News Feature articles General Information   Full Text Title

The Market Industry News Regulatory News General Health Legal/IPR News Product/R&D News API/Bulk Drug News People in the News Other News Top News Worldwide News In Focus Editorials Commentaries Expert Opinions Interviews Case Studies Company Profiles Editor’s Picks

MOH issues China’s first national formulary The MOH announced the launch of “Chinese National Formulary (Chemical Drugs and Biological Products Volume)” – the first of its kind ever in China – on February 7.... (2/8/2010) China’s Foreign Trade of Western Medicines in 2009 and Outlook for 2010 (2/8/2010) Overview of the Chinese Vaccine Market 2006-2009 (2/8/2010) 2009 Judicial Interpretation Offer Guidelines for Applying Criminal Law to Fake Drug and Inferior Drug Cases (2/3/2010) Gastric Cancer Treatment in China: Significantly Different versus G7 Countries (1/29/2010) Pharma MNCs Elevate China Business as Tension Builds between the Country and the U.S. (1/25/2010) What China can learn from Taiwan: patient advocacy groups as health literacy enablers (1/25/2010) Flexible Pricing Policy Pays Off in Diverse Drugs Market (External) (1/22/2010) IMS Health: All Eyes on Chinese healthcare market (1/21/2010) TCM hospitals may spearhead public hospital reform (1/15/2010) Mixed Results For China Life Science US IPOs (External) (1/4/2010) More Shoes of Healthcare Reform Drop, But Uncertainties Remain with Local Implementations (1/4/2010) Emerging Drug Delivery Systems for the Development of Biopharmaceuticals (External) (12/15/2009) The Impact of Chinese Health Care Reforms - Survey Findings and Observations by ZS (12/9/2009) 2010 Products and Therapy Areas to Watch (12/4/2009) China Takes Aim at RNAi (12/2/2009) MOH issues China’s first national formulary  (2/8/2010) MOC encourages consolidation in the Chinese pharma distribution sector  (2/8/2010) Hengrui posts substantial revenue and net profit growth in 2009  (2/8/2010) 3SBio licenses hyperphosphatemia drug from Panacor  (2/8/2010) BioMarin to acquire LEAD Therapeutics  (2/8/2010) Hisun to acquire 4.5% stake in Sagent Pharma  (2/8/2010) Pfizer initiates e-payment system in emerging markets  (2/8/2010) MOH drafts a new hospital drug purchase tender guidelines amid rising complaints from the industry  (2/5/2010) Pfizer initiates e-payment system in emerging markets Foreign drug companies may lose exclusivity for some dru... Spectrum licenses rights of cancer drug candidate for ce... Pfizer wants to be the top generic drug player in Japan New report urges pharma giants to externalize drug devel... Recent survey reveals medicine cabinets of Chinese families CNMA ranks leading OTC companies and brand names in 2008 BMI forecasts double digit CAGR for Chinese pharma market throu... Nicholas Hall: Chinese OTC market rose faster last year and wil... China to improve market access to India pharma companies MOC encourages consolidation in the Chinese pharma distribut... Hengrui posts substantial revenue and net profit growth in 2... 3SBio licenses hyperphosphatemia drug from Panacor BioMarin to acquire LEAD Therapeutics Hisun to acquire 4.5% stake in Sagent Pharma SFDA to explore reform of China’s drug regulatory regim... MOH and SFDA initiate professional training program for ... SFDA to emphasize on essential drug safety in 2010 Guangdong implements differential drug pricing SFDA orders crackdown on illegal drug advertisements China issues implementation regulation for the third amendme... "2009 USTR Report on China’s WTO Compliance" highlights con... SFDA issues the No.143 and No.144 announcements of drug admi... Compulsory licensing of Tamiflu requested in China Chinese government conditionally approves Pfizer-Wyeth merge... NDRC to halt bulk vitamin C expansion wave in China Xinchang Pharma passes USFDA inspection for bulk antimal... Baiyunshan Pharma and DSM enter strategic alliance Paper: EU authorities only inspect Chinese pharma factor... New York Times: Chinese chemicals flow unchecked onto wo... New report highlights prospects and challenges of drug d... Guangzhou Huacheng Pharma completes phase III trials of ... Pacgen and New Summit Biopharma reach agreement to devel... MDRNA receives Chinese patent for use of nucleic acids f... Bayer Schering Pharma initiates phase IV study ADVISE in... MOH issues China’s first national formulary MOH drafts a new hospital drug purchase tender guideline... MOH releases 2009 healthcare statistics Guangdong to initiate centralized hospital drug purchase... The State Council approves public hospital reform plan China Biologic appoints a new independent director New official appointments at the SFDA China Aoxing Pharma appoints new CFO Top executive at BMP Sunstone resigns Board member changes at Nepstar and Biostar Pharma Upcoming Event: Pharma China Forum 2010 in Beijing Upcoming Event: Pharma China Seminar 2010 in New Jersey Chinese and Austrian health ministers meet in Beijing WellPoint to establish a health insurance JV in China Upcoming event: Pharmaceutical Regulatory Affairs Confer... se pharmaceutical  and biopharmaceutical sector.  Pharma China is published by WiCON International Group LLC, a leading information and consulting firm which has been helping international healthcare companies su... WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...   Pharma China adds one more dis...   WiCON Launches China Pharmaceu...   Pharma China adds another dist...   Testimonials from subscribers ...   Pharma China to Initiate Selec...

© Wicon International Group　Support by: www.heightow.com Site map | Contact Us | Links